Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 28 June 2002:
Vol. 296. no. 5577, pp. 2404 - 2407
DOI: 10.1126/science.1070200
Prev | Table of Contents | Next

Reports

Tumor Regression by Targeted Gene Delivery to the Neovasculature

John D. Hood,1 Mark Bednarski,2 Ricardo Frausto,1 Samira Guccione,2 Ralph A. Reisfeld,1 Rong Xiang,1 David A. Cheresh1*

Efforts to influence the biology of blood vessels by gene delivery have been hampered by a lack of targeting vectors specific for endothelial cells in diseased tissues. Here we show that a cationic nanoparticle (NP) coupled to an integrin alpha vbeta 3-targeting ligand can deliver genes selectively to angiogenic blood vessels in tumor-bearing mice. The therapeutic efficacy of this approach was tested by generating NPs conjugated to a mutant Raf gene, ATPµ-Raf, which blocks endothelial signaling and angiogenesis in response to multiple growth factors. Systemic injection of the NP into mice resulted in apoptosis of the tumor-associated endothelium, ultimately leading to tumor cell apoptosis and sustained regression of established primary and metastatic tumors.

1 Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 Lucas Magnetic Resonance Spectroscopy Research Center, Stanford School of Medicine, 1201 Welch Road, Stanford, CA 94305, USA.
*   To whom correspondence should be addressed. E-mail: cheresh{at}scripps.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery.
K. Osada, R. J. Christie, and K. Kataoka (2009)
J R Soc Interface 6, S325-S339
   Abstract »    Full Text »    PDF »
CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy.
S. H. Thorne, Y. Barak, W. Liang, M. H. Bachmann, J. Rao, C. H. Contag, and A. Matin (2009)
Mol. Cancer Ther. 8, 333-341
   Abstract »    Full Text »    PDF »
Snail Regulates Cell-Matrix Adhesion by Regulation of the Expression of Integrins and Basement Membrane Proteins.
M. Haraguchi, T. Okubo, Y. Miyashita, Y. Miyamoto, M. Hayashi, T. N. Crotti, K. P. McHugh, and M. Ozawa (2008)
J. Biol. Chem. 283, 23514-23523
   Abstract »    Full Text »    PDF »
Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors.
L. Dal Lago, V. D'Hondt, and A. Awada (2008)
Oncologist 13, 845-858
   Abstract »    Full Text »    PDF »
From the Cover: Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.
(2008)
PNAS 105, 9343-9348
Nanomedicine Captures Cardiovascular Disease.
W. J.M. Mulder and Z. A. Fayad (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 801-802
   Full Text »    PDF »
Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
A. Van Langendonckt, J. Donnez, S. Defrere, G. A.J. Dunselman, and P. G. Groothuis (2008)
Mol. Hum. Reprod. 14, 259-268
   Abstract »    Full Text »    PDF »
Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis.
S.-C. Chen, D. O. Henry, P. R. Reczek, and M. K.K. Wong (2008)
Mol. Cancer Ther. 7, 1227-1236
   Abstract »    Full Text »    PDF »
Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival.
M. R. Junttila, S.-P. Li, and J. Westermarck (2008)
FASEB J 22, 954-965
   Abstract »    Full Text »    PDF »
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma.
Y. Ding, E. A. Boguslawski, B. D. Berghuis, J. J. Young, Z. Zhang, K. Hardy, K. Furge, E. Kort, A. E. Frankel, R. V. Hay, et al. (2008)
Mol. Cancer Ther. 7, 648-658
   Abstract »    Full Text »    PDF »
Combining Agents that Target the Tumor Microenvironment Improves the Efficacy of Anticancer Therapy.
J. A. Blansfield, D. Caragacianu, H. R. Alexander III, M. A. Tangrea, S. Y. Morita, D. Lorang, P. Schafer, G. Muller, D. Stirling, R. E. Royal, et al. (2008)
Clin. Cancer Res. 14, 270-280
   Abstract »    Full Text »    PDF »
CCR Drug Updates: Sorafenib and Sunitinib in Renal Cell Carcinoma.
M. N. Stein and K. T. Flaherty (2007)
Clin. Cancer Res. 13, 3765-3770
   Full Text »    PDF »
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.
M. A. Venneri, M. D. Palma, M. Ponzoni, F. Pucci, C. Scielzo, E. Zonari, R. Mazzieri, C. Doglioni, and L. Naldini (2007)
Blood 109, 5276-5285
   Abstract »    Full Text »    PDF »
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis.
R. R. Langley and I. J. Fidler (2007)
Endocr. Rev. 28, 297-321
   Abstract »    Full Text »    PDF »
Nano- and Microparticle-based Imaging of Cardiovascular Interventions: Overview.
X. Yang (2007)
Radiology 243, 340-347
   Abstract »    Full Text »    PDF »
Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1-Mediated Inhibition of the Proapoptotic Kinase, ASK1.
A. S. Alavi, L. Acevedo, W. Min, and D. A. Cheresh (2007)
Cancer Res. 67, 2766-2772
   Abstract »    Full Text »    PDF »
Sorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer.
C. Gridelli, P. Maione, F. Del Gaizo, G. Colantuoni, C. Guerriero, C. Ferrara, D. Nicolella, D. Comunale, A. De Vita, and A. Rossi (2007)
Oncologist 12, 191-200
   Abstract »    Full Text »    PDF »
Sorafenib in Renal Cell Carcinoma.
K. T. Flaherty (2007)
Clin. Cancer Res. 13, 747s-752s
   Abstract »    Full Text »    PDF »
Favorable Biokinetic and Tumor-Targeting Properties of 99mTc-Labeled Glucosamino RGD and Effect of Paclitaxel Therapy.
K.-H. Jung, K.-H. Lee, J.-Y. Paik, B.-H. Ko, J.-S. Bae, B. C. Lee, H. J. Sung, D. H. Kim, Y. S. Choe, and D. Y. Chi (2006)
J. Nucl. Med. 47, 2000-2007
   Abstract »    Full Text »    PDF »
cNGR: A Novel Homing Sequence for CD13/APN Targeted Molecular Imaging of Murine Cardiac Angiogenesis In Vivo.
A. Buehler, M. A.M.J. van Zandvoort, B. J. Stelt, T. M. Hackeng, B. H.G.J. Schrans-Stassen, A. Bennaghmouch, L. Hofstra, J. P.M. Cleutjens, A. Duijvestijn, M. B. Smeets, et al. (2006)
Arterioscler. Thromb. Vasc. Biol. 26, 2681-2687
   Abstract »    Full Text »    PDF »
Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy..
F. Pastorino, C. Brignole, D. Di Paolo, B. Nico, A. Pezzolo, D. Marimpietri, G. Pagnan, F. Piccardi, M. Cilli, R. Longhi, et al. (2006)
Cancer Res. 66, 10073-10082
   Abstract »    Full Text »    PDF »
Cortical Migration Defects in Mice Expressing A-RAF from the B-RAF Locus..
G. Camarero, O. Y. Tyrsin, C. Xiang, V. Pfeiffer, S. Pleiser, S. Wiese, R. Gotz, and U. R. Rapp (2006)
Mol. Cell. Biol. 26, 7103-7115
   Abstract »    Full Text »    PDF »
Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development..
N. Young, C. N. Hahn, A. Poh, C. Dong, D. Wilhelm, J. Olsson, G. E. O. Muscat, P. Parsons, J. R. Gamble, and P. Koopman (2006)
J Natl Cancer Inst 98, 1060-1067
   Abstract »    Full Text »    PDF »
Transduction of a Mesenchyme-specific Gene Periostin into 293T Cells Induces Cell Invasive Activity through Epithelial-Mesenchymal Transformation.
W. Yan and R. Shao (2006)
J. Biol. Chem. 281, 19700-19708
   Abstract »    Full Text »    PDF »
Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma..
D. J. Panka, M. B. Atkins, and J. W. Mier (2006)
Clin. Cancer Res. 12, 2371s-2375s
   Abstract »    Full Text »    PDF »
Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate.
A. P. Hall, F. R. Westwood, and P. F. Wadsworth (2006)
Toxicol Pathol 34, 131-147
   Abstract »    Full Text »    PDF »
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.
G. Zheng, J. Chen, H. Li, and J. D. Glickson (2005)
PNAS 102, 17757-17762
   Abstract »    Full Text »    PDF »
Raf: A Strategic Target for Therapeutic Development Against Cancer.
M. Beeram, A. Patnaik, and E. K. Rowinsky (2005)
J. Clin. Oncol. 23, 6771-6790
   Abstract »    Full Text »    PDF »
Inhibition of Tumor Growth by RGD Peptide-Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature.
T. Kessler, R. Bieker, T. Padro, C. Schwoppe, T. Persigehl, C. Bremer, M. Kreuter, W. E. Berdel, and R. M. Mesters (2005)
Clin. Cancer Res. 11, 6317-6324
   Abstract »    Full Text »    PDF »
64Cu-Labeled Folate-Conjugated Shell Cross-Linked Nanoparticles for Tumor Imaging and Radiotherapy: Synthesis, Radiolabeling, and Biologic Evaluation.
R. Rossin, D. Pan, K. Qi, J. L. Turner, X. Sun, K. L. Wooley, and M. J. Welch (2005)
J. Nucl. Med. 46, 1210-1218
   Abstract »    Full Text »    PDF »
Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas.
S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao (2005)
J. Biol. Chem. 280, 21882-21892
   Abstract »    Full Text »    PDF »
Nanomedicine: current status and future prospects.
S. M. Moghimi, A. C. Hunter, and J. C. Murray (2005)
FASEB J 19, 311-330
   Abstract »    Full Text »    PDF »
Antibody phage display technologies with special reference to angiogenesis.
J. Smith, R. E. Kontermann, J. Embleton, and S. Kumar (2005)
FASEB J 19, 331-341
   Abstract »    Full Text »    PDF »
Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors.
D. Strumberg, H. Richly, R. A. Hilger, N. Schleucher, S. Korfee, M. Tewes, M. Faghih, E. Brendel, D. Voliotis, C. G. Haase, et al. (2005)
J. Clin. Oncol. 23, 965-972
   Abstract »    Full Text »    PDF »
Ultrasonic Imaging of Tumor Angiogenesis Using Contrast Microbubbles Targeted via the Tumor-Binding Peptide Arginine-Arginine-Leucine.
G. E.R. Weller, M. K.K. Wong, R. A. Modzelewski, E. Lu, A. L. Klibanov, W. R. Wagner, and F. S. Villanueva (2005)
Cancer Res. 65, 533-539
   Abstract »    Full Text »    PDF »
Anastellin, a Fragment of the First Type III Repeat of Fibronectin, Inhibits Extracellular Signal-Regulated Kinase and Causes G1 Arrest in Human Microvessel Endothelial Cells.
A. Ambesi, R. M. Klein, K. M. Pumiglia, and P. J. McKeown-Longo (2005)
Cancer Res. 65, 148-156
   Abstract »    Full Text »    PDF »
Disruption of the Rb-Raf-1 Interaction Inhibits Tumor Growth and Angiogenesis.
P. Dasgupta, J. Sun, S. Wang, G. Fusaro, V. Betts, J. Padmanabhan, S. M. Sebti, and S. P. Chellappan (2004)
Mol. Cell. Biol. 24, 9527-9541
   Abstract »    Full Text »    PDF »
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
R. M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm, G. Molema, P. Y. Lu, P. V. Scaria, and M. C. Woodle (2004)
Nucleic Acids Res. 32, e149
   Abstract »    Full Text »    PDF »
Delivery of a Liposomal c-raf-1 Antisense Oligonucleotide by Weekly Bolus Dosing in Patients with Advanced Solid Tumors: A Phase I Study.
C. M. Rudin, J. L. Marshall, C. H. Huang, H. L. Kindler, C. Zhang, D. Kumar, P. C. Gokhale, J. Steinberg, S. Wanaski, U. N. Kasid, et al. (2004)
Clin. Cancer Res. 10, 7244-7251
   Abstract »    Full Text »    PDF »
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.
S. Weis, J. Cui, L. Barnes, and D. Cheresh (2004)
J. Cell Biol. 167, 223-229
   Abstract »    Full Text »    PDF »
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis.
S. M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, H. Rong, C. Chen, X. Zhang, P. Vincent, M. McHugh, et al. (2004)
Cancer Res. 64, 7099-7109
   Abstract »    Full Text »    PDF »
Suppression of Tumor Growth and Angiogenesis in Vivo by a Truncated Form of 24-kd Fibroblast Growth Factor (FGF)-2.
E. G. Levin, L. Sikora, L. Ding, S. P. Rao, and P. Sriramarao (2004)
Am. J. Pathol. 164, 1183-1190
   Abstract »    Full Text »    PDF »
Functional endothelial cells derived from rhesus monkey embryonic stem cells.
D. S. Kaufman, R. L. Lewis, E. T. Hanson, R. Auerbach, J. Plendl, and J. A. Thomson (2004)
Blood 103, 1325-1332
   Abstract »    Full Text »    PDF »
Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with {alpha}v{beta}3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth1.
J. J. Pereira, T. Meyer, S. E. Docherty, H. H. Reid, J. Marshall, E. W. Thompson, J. Rossjohn, and J. T. Price (2004)
Cancer Res. 64, 977-984
   Abstract »    Full Text »    PDF »
Insulin-like Growth Factor-independent Effects Mediated by a C-terminal Metal-binding Domain of Insulin-like Growth Factor Binding Protein-3.
B. Singh, D. Charkowicz, and D. Mascarenhas (2004)
J. Biol. Chem. 279, 477-487
   Abstract »    Full Text »    PDF »
JAM-1 Regulation of Endothelial Cell Migration: Implications for Angiogenesis.
L. V. Parise (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 2119-2120
   Full Text »    PDF »
Angiogenesis imaging in the post-genomic era.
K C P Li (2003)
Br. J. Radiol. 76, S1-S2
   Full Text »    PDF »
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.
S. Christian, J. Pilch, M. E. Akerman, K. Porkka, P. Laakkonen, and E. Ruoslahti (2003)
J. Cell Biol. 163, 871-878
   Abstract »    Full Text »    PDF »
Vascular Damage and Anti-angiogenic Effects of Tumor Vessel-Targeted Liposomal Chemotherapy.
F. Pastorino, C. Brignole, D. Marimpietri, M. Cilli, C. Gambini, D. Ribatti, R. Longhi, T. M. Allen, A. Corti, and M. Ponzoni (2003)
Cancer Res. 63, 7400-7409
   Abstract »    Full Text »    PDF »
Treatment of Metastatic Melanoma with an Orally Available Inhibitor of the Ras-Raf-MAPK Cascade.
E. A. Collisson, A. De, H. Suzuki, S. S. Gambhir, and M. S. Kolodney (2003)
Cancer Res. 63, 5669-5673
   Abstract »    Full Text »    PDF »
Differential {alpha}v integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.
J. D. Hood, R. Frausto, W. B. Kiosses, M. A. Schwartz, and D. A. Cheresh (2003)
J. Cell Biol. 162, 933-943
   Abstract »    Full Text »    PDF »
Building a better Trap.
J. D. Hood and D. A. Cheresh (2003)
PNAS 100, 8624-8625
   Full Text »    PDF »
Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli.
A. Alavi, J. D. Hood, R. Frausto, D. G. Stupack, and D. A. Cheresh (2003)
Science 301, 94-96
   Abstract »    Full Text »    PDF »
p38 Mitogen-activated Protein Kinase Pathway Suppresses Cell Survival by Inducing Dephosphorylation of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase1,2.
S.-P. Li, M. R. Junttila, J. Han, V.-M. Kahari, and J. Westermarck (2003)
Cancer Res. 63, 3473-3477
   Abstract »    Full Text »    PDF »
Erythropoietin regulates tumour growth of human malignancies.
Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, A. Tazaki, M. Onozaki, M. Hashimoto, T. Musha, K. Ogawa, et al. (2003)
Carcinogenesis 24, 1021-1029
   Abstract »    Full Text »    PDF »
Early Events in the Anoikis Program Occur in the Absence of Caspase Activation.
P. Wang, A. J. Valentijn, A. P. Gilmore, and C. H. Streuli (2003)
J. Biol. Chem. 278, 19917-19925
   Abstract »    Full Text »    PDF »
The hepatitis C virus internal ribosome entry site facilitates efficient protein synthesis in blood vessel endothelium during tumour angiogenesis.
G. T. Y. Chung, Y. Yamada, R. Pannell, A. Forster, and T. H. Rabbitts (2003)
Nucleic Acids Res. 31, e46
   Abstract »    Full Text »    PDF »
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.
P. S. Bora, Z. Hu, T. H. Tezel, J.-H. Sohn, S. G. Kang, J. M. C. Cruz, N. S. Bora, A. Garen, and H. J. Kaplan (2003)
PNAS 100, 2679-2684
   Abstract »    Full Text »    PDF »
Nanocrystal targeting in vivo.
M. E. Akerman, W. C. W. Chan, P. Laakkonen, S. N. Bhatia, and E. Ruoslahti (2002)
PNAS 99, 12617-12621
   Abstract »    Full Text »    PDF »
Novel Gene Therapy for Angiogenesis Inhibition Stops Cancer in Mice.
(2002)
Journal Watch (General) 2002, 3
   Full Text »
Targeted Delivery of Mutant Raf Kinase to Neovessels Causes Tumor Regression.
J.D. HOOD and D.A. CHERESH (2002)
Cold Spring Harb Symp Quant Biol 67, 285-292
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)